SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is gaining traction as community members highlight its role in providing high-speed data feeds for real-world assets and major institutional partners. Enthusiasts are actively debating the network's shift toward a paid service model and its potential as a critical infrastructure layer alongside established oracle competitors.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is garnering investor attention due to its central role in powering real-world asset (RWA) tokenization and institutional financial infrastructure. Community discussion is heavily focused on its long-term utility and partnerships, with many users employing dollar-cost averaging strategies while debating whether current market sentiment undervalues the project's foundational role in the evolving digital economy.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck & Co. is trending due to intensified buyout speculation as the pharmaceutical giant navigates the looming patent expiration of its blockbuster drug, Keytruda, while investors debate the potential acquisition of promising oncology platform developers. Community discussion is heavily focused on the competitive landscape of the biotech sector, with participants analyzing buyout valuations and identifying potential targets like Sellas Life Sciences that could bolster Merck's pipeline.

Vanguard Index Funds - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF is trending as investors favor broad-market index funds over individual stock picking to navigate market volatility and macro uncertainty. The community is actively discussing the benefits of a set-and-forget strategy for long-term compounding, with many highlighting the fund's low expense ratio and comprehensive exposure to the U.S. economy as a reliable safe haven amidst fluctuating market conditions.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is trending as investors weigh strong earnings expectations and ongoing digital payments growth against regulatory headwinds, including proposed caps on credit card interest rates. The community is actively debating the stock's resilience, focusing on whether high-quality cash generation and strategic blockchain initiatives can offset competitive and policy-driven risks.

Lionsgate Studios Corp. operates as a standalone, pure-play content company focused on creating, producing, and distributing premium entertainment across multiple formats and platforms. It operates through the following segments: Motion Picture and Television Production. The Motion Picture segment includes the development and production of feature films, acquisition of North American and worldwide distribution rights, North American theatrical, home entertainment, and television distribution of produced and acquired films, as well as the worldwide licensing of distribution rights. The Television Production segment covers the development, production, and worldwide distribution of television content, including series, television movies, mini-series, and non-fiction programming. The company was founded on January 13, 2024 and is headquartered in Vancouver, Canada.

Lionsgate Studios Corp. - Ordinary Shares - New

Lionsgate Studios Corp.

Lionsgate Studios is trending as investors digest acquisition interest from the Apollo-backed Legendary Entertainment, fueling ongoing community speculation about a potential buyout. Market participants are actively debating the viability of a takeover, citing the studio's deep content library and recent ownership restructuring as key drivers for a premium valuation.

TELUS Corp. is a telecommunications company, which engages in the provision of telecommunication services and products primarily for wireless and wireline voice and data. It operates through TELUS Technology Solutions (TTech) and Digitally-led Customer Experiences–TELUS International (DLCX) segments. The TTech segment includes network revenues and equipment sales arising from mobile technologies, data revenues, healthcare software and technology solutions, voice and other telecommunications services revenues, and equipment sales. The DLCX segment is composed of digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions, provided by TELUS International. The company was founded on October 4, 1990 and is headquartered in Vancouver, Canada.

Telus Corp.

Telus is seeing significant volatility as investors debate the impact of potential dividend adjustments, rising debt, and ongoing cost-cutting measures. The community remains deeply divided, with some highlighting the company's long-term value and AI infrastructure investments, while others express frustration over share dilution and the sustainability of payouts.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending following the publication of groundbreaking Phase 3 trial data for daraxonrasib, which demonstrated a significant survival benefit in metastatic pancreatic cancer. The oncology community is actively discussing the drug's potential as a new standard of care, leading to heavy institutional interest and speculation regarding its value as a premier target for large-scale pharmaceutical acquisitions.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is trending as investors focus on the commercial launch momentum of its FDA-approved gene therapy, ZEVASKYN, and its pivot toward near-term profitability. Community discussion highlights the stock's potential as a highly undervalued play supported by a strong cash position, low debt, and an expanding network of qualified treatment centers.

GLOBALFOUNDRIES, Inc. provides foundry services and manufactures semiconductors. It offers global shuttle, mask, post-fab and turnkey services. The company was founded on October 7, 2008 and is headquartered in Malta, NY.

GlobalFoundries Inc

GlobalFoundries is currently generating investor interest as a vital player in the U.S. semiconductor reshoring and AI infrastructure narrative, driven by its specialized manufacturing capabilities and government-backed quantum initiatives. The community remains focused on the company's potential to scale alongside next-generation technologies, though some discussions highlight concerns regarding liquidity overhangs from major block sales.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HSBC Sees Strongest US Q2 Earnings Growth Since Post-Pandemic Era — Energy, Tech And Materials Sectors To Shine

Equity

An analysis by HSBC Global Investment Research reveals that U.S. corporate earnings expectations are climbing at their fastest pace since the post-pandemic recovery era.

Energy ETFs Worth Watching as Hormuz Shipping Risks Persist

A fragile U.S.-Iran truce and Hormuz risks could keep oil prices elevated. Here are some energy ETFs investors may want to watch.

Energy ETFs to Buy as Oil Price Slides to Pre-Iran War Level

Oil prices have fallen back to pre-war levels, but energy ETFs may still offer opportunity as refining, LNG demand, and tight supply support the sector.  

Should You Invest in the Vanguard Energy Index Fund ETF Shares (VDE)?

Energy ETFs Worth Considering Amid Oil Pullback and Supply Constraints

Markets cheer easing tensions while overlooking persistent supply risks in energy markets. Here we discuss some energy ETFs investors may want to watch.

Energy ETFs Could Be Positioned for More Gains: Here's Why

Elusive Iran peace talks and persistent supply risks are strengthening the case for higher-for-longer oil prices. Here are some energy ETFs investors may want to watch.

DVN Stock Falls Premarket, But This Analyst Sees 37% Upside Amid Bullish Oil Backdrop

Barclays raised the price target on Devon Energy to $62 from $54 and kept an ‘Overweight’ rating on the shares.

Energy ETFs to Keep Shining Amid Elusive Peace Deal and Supply Risks

Elusive Iran peace talks and supply risks keep the bullish case for energy markets intact. Check these energy ETFs to ride the upside.

Oil to Stay Elevated Above Pre-Conflict Levels: Energy ETFs to Benefit

Energy ETFs gain appeal as oil prices are expected stay above pre-conflict levels, with supply shocks, stalled Iran talks & tight markets indicating sustained price strength.

Energy ETFs to Shine Amid Supply Constraints and Elusive Peace Talks

Supply risks and stalled diplomacy may keep oil prices higher. Check these energy ETFs to ride the upside.

Vanguard World Fund - Vanguard Energy ETF

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is pacing for a losing week as a semiconductor ($SMH) sell-off has dragged the market lower amid growing doubts about AI spending. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$162.78
Prev Close	$160.76
Open	$163.13
Dividend Yield	N/A
50-Day Moving Average	$159.78
Beta	N/A
Avg. Volume	824,558.08
PE Ratio	N/A

52-Week High	$179.34
52-Week Low	$118.17
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

VDEVanguard Energy ETF

Latest VDE News